Abstract
Late outgrowth endothelial cells (OECs) that originate from peripheral blood mononuclear cells ex vivo have phenotypic and functional properties of mature endothelial cells. Given the potential therapeutic applications of OECs, understanding their biology is crucial. We have identified two distinct OEC populations based on differential expression of the cell surface marker CD34. OEC colonies lacked CD34 expression (CD34−), expressed CD34 in the majority of cells (CD34+), or showed a mixed expression pattern within a colony (CD34+/−). CD34+ and CD34− OECs were negative for hematopoietic cell marker CD45 and expressed the endothelial cell surface markers CD31, CD146, CD105, and VEGFR-2. Functionally CD34− and CD34+ OECs exhibited strikingly distinct behaviors. CD34− OECs, unlike CD34+ OECs, were capable of sprouting, formed tubes, and responded to angiogenic growth factors in vitro. In vivo, CD34− OECs formed endothelial tubes, while CD34+ OECs, despite being unable to form tubes, promoted infiltration of murine vasculature. Global gene expression profiling in CD34− and CD34+ OECs identified functional importance of the MMP-1/PAR-1 pathway in CD34− OECs. MMP-1 stimulated the expression of VEGFR-2, neuropilin-1, neuropilin-2, and CXCR4 and activated ERK1/2, whereas down-regulation of PAR-1 in CD34− OECs resulted in impaired angiogenic responses in vitro and reduced VEGFR-2 levels. In contrast, the CD34+ OEC colonies expressed high levels of the progenitor cell marker ALDH, which was absent in CD34− OECs. In summary, we show that OECs can be classified into functionally mature endothelial cells (CD34− OECs) that depend on the MMP-1/PAR-1 pathway and progenitor-like angiogenesis-promoting cells (CD34+ OECs).
Similar content being viewed by others
References
Fadini GP, Losordo D, Dimmeler S (2012) Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 110:624–637
Hirschi KK, Ingram DA, Yoder MC (2008) Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:1584–1595
Ingram DA, Mead LE, Tanaka H et al (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752–2760
Yoder MC, Mead LE, Prater D et al (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801–1809
Roncalli JG, Tongers J, Renault MA, Losordo DW (2008) Endothelial progenitor cells in regenerative medicine and cancer: a decade of research. Trends Biotechnol 26:276–283
Rouhl RP, van Oostenbrugge RJ, Damoiseaux J et al (2008) Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke 39:2158–2165
Dudek AZ (2010) Endothelial lineage cell as a vehicle for systemic delivery of cancer gene therapy. Transl Res 156:136–146
Bodempudi V, Ohlfest JR, Terai K et al (2010) Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumours. Cancer Gene Ther 17:855–863
Sieveking DP, Buckle A, Celermajer DS, Ng MK (2008) Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 51:660–668
Bieback K, Vinci M, Elvers-Hornung S et al (2013) Recruitment of human cord blood-derived endothelial colony-forming cells to sites of tumour angiogenesis. Cytotherapy 15:1–14
Martin-Ramirez J, Hofman M, van den Biggelaar M et al (2012) Establishment of outgrowth endothelial cells from peripheral blood. Nat Protoc 7:1709–1715
Cole CL, Hansen SU, Baráth M et al (2010) Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis. PLoS ONE 5:e11644
Ferreras C, Rushton G, Cole CL et al (2012) Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. J Biol Chem 287:36132–36146
Albig AR, Schiemann WP (2005) Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling. Mol Biol Cell 16:609–625
Goerge T, Barg A, Schnaeker EM et al (2006) Tumour-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation. Cancer Res 66:7766–7774
Boncela J, Przygodzka P, Wyroba E et al (2013) Secretion of SerpinB2 from endothelial cells activated with inflammatory stimuli. Exp Cell Res 319:1213–1219
Sato Y, Okamura K, Morimoto A et al (1993) Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro. Exp Cell Res 204:223–229
Kroon ME, Koolwijk P, van der Vecht B, van Hinsbergh VW (2000) Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix. Blood 96:2775–2783
Krneta J, Kroll J, Alves F et al (2006) Dissociation of angiogenesis and tumourigenesis in follistatin- and activin-expressing tumours. Cancer Res 66:5686–5695
Schreiber AB, Winkler ME, Derynck R (1986) Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science 232:1250–1253
Fantin A, Vieira JM, Plein A et al (2013) NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. Blood 121(12):2352–2362
Favier B, Alam A, Barron P et al (2006) Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108(4):1243–1250
Austin KM, Covic L, Kuliopulos A (2013) Matrix metalloproteases and PAR-1 activation. Blood 121:431–439
Smadja DM, Bieche I, Uzan G et al (2005) PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system. Arterioscler Thromb Vasc Biol 25:2321–2327
Basire A, Sabatier F, Ravet S et al (2006) High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors. Thromb Haemost 95:678–688
Varani J, Perone P, Warner RL et al (2008) Vascular tube formation on matrix metalloproteinase-1-damaged collagen. Br J Cancer 98:1646–1652
Mazor R, Alsaigh T, Shaked H et al (2013) Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells. J Biol Chem 288:598–607
Jiang A, Pan W, Milbauer LC et al (2007) A practical question based on cross-platform microarray data normalization: are OECS more like large vessel or microvascular endothelial cells or neither of them? J Bioinform Comput Biol 5:875–893
Urbich C, Dimmeler S (2004) Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14:318–322
Khodarev NN, Yu J, Labay E et al (2003) Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci 116:1013–1022
Wang Z, Kong D, Banerjee S et al (2007) Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling. Cancer Res 67:11377–11385
Weber KS, Nelson PJ, Gröne HJ et al (1999) Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium. Arterioscler Thromb Vasc Biol 19:2085–2093
Kozian DH, Ziche M, Augustin HG (1997) The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab Invest 76:267–276
Timmermans F, Plum J, Yoder MC et al (2008) Endothelial progenitor cells: identity defined? J Cell Mol Med 13:87–102
Masuda H, Alev C, Akimaru H et al (2011) Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res 109:20–37
Gunetti M, Noghero A, Molla F et al (2011) Ex vivo-expanded bone marrow cd34(+) for acute myocardial infarction treatment: in vitro and in vivo studies. Cytotherapy 13:1140–1152
Tura O, Skinner EM, Barclay GR et al (2013) Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow. Stem Cells 31:338–348
Ingram DA, Mead LE, Moore DB et al (2005) Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105:2783–2786
de la Puente P, Muz B, Azab F et al (2013) Cell trafficking of endothelial progenitor cells in tumour progression. Clin Cancer Res 19:3360–336839
Rancourt C, Robertson MW 3rd, Wang M et al (1998) Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary. Clin Cancer Res 4:265–270
Dudek AZ, Bodempudi V, Welsh BW et al (2007) Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy. Br J Cancer 97:513–522
Acknowledgments
The authors are grateful to Cancer Research, UK, which funded this work (C2075/A11994).
Conflict of interest
The authors declare no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Gordon C. Jayson and Egle Avizienyte have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Ferreras, C., Cole, C.L., Urban, K. et al. Segregation of late outgrowth endothelial cells into functional endothelial CD34− and progenitor-like CD34+ cell populations. Angiogenesis 18, 47–68 (2015). https://doi.org/10.1007/s10456-014-9446-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10456-014-9446-1